Author

E Cardó

Observed names: E Cardo, E. Cardo, Esther Cardo

Observed institutions: Hospital Sant Joan de Déu Barcelona, Hospital Son Llatzer, Hospital Clínic de Barcelona, Municipal Institute for Medical Research, Research Institute of Health Sciences, Universitat de les Illes Balears, Universitat de Barcelona

OpenAlex ID: A5113481113

Levels of hexachlorobenzene and other organochlorine compounds in cord blood: exposure across placenta

2001 · M Sala, N Ribas-Fitó, et al. · Chemosphere · 162

Organochlorine compounds and concentrations of thyroid stimulating hormone in newborns: Table 1

2003 · N Ribas-Fitó, M Sala, et al. · Occupational and Environmental Medicine · 63

PDF

Clinical, enzymatic, and molecular genetic characterization of a biochemical variant type of argininosuccinic aciduria: prenatal and postnatal diagnosis in five unrelated families

2002 · W. J. Kleijer, V. H. Garritsen, et al. · Journal of Inherited Metabolic Disease · 43

Fatal haemorrhagic infarct in an infant with homocystinuria

1999 · E Cardo, J Campistol, et al. · Developmental Medicine & Child Neurology · 24

PDF

[The prevalence of attention deficit hyperactivity disorder].

2005 · E Cardo, M Servera-Barceló · PubMed · 14

[Soft neurological signs: are they of any value in the assessment and diagnosis of attention deficit hyperactivity disorder?].

2008 · E Cardo, S Casanovas, et al. · PubMed · 13

Phosphomannomutase deficiency and normal pubertal development

1998 · J. Artigas, E. Cardo, et al. · Journal of Inherited Metabolic Disease · 13

[The influence of different diagnostic criteria and the culture on the prevalence of attention deficit hyperactivity disorder].

2011 · Esther Cardo, Mateu Servera, et al. · PubMed · 10

¿Cuál es la combinación de síntomas según padres y maestros más fiable para el diagnóstico de TDAH?

2009 · E. Cardo, M. Bustillo, et al. · Anales de Pediatría · 5

[The role of resistance to C active protein (R-APC) in a pediatric stroke].

1997 · E Cardo, J Campistol, et al. · PubMed · 3

P-312 - Prognostic factors of improvement in health related quality of life in children and adolescents with attention deficit/hyperactivity disorder, after atomoxetine treatment

2012 · A. Montoya, D. Quail, et al. · European Psychiatry · 2

[The predictive value of DSM-IV criteria in the diagnosis of attention deficit hyperactivity disorder and its cultural differences].

2007 · E Cardo, M Bustillo, et al. · PubMed · 2

[Prenatal cerebrovascular accidents: their incidence, pathogenesis and risk factors].

2006 · E Cardó, M Juan · PubMed · 2

[Current state of the attention deficit hyperactivity disorder approach in neuropediatrics].

2017 · E Cardo, G Ros-Cervera, et al. · PubMed · 1

[Attention deficit disorder and hyperactivity: a pattern of evolution?].

2010 · E Cardo, A Nevot, et al. · PubMed · 1

[Oppositional defiant disorder: aspects related to sex differences and informant].

2009 · E Cardo, V Meisel, et al. · PubMed · 1

EPA-0775 – Efficacy of lisdexamfetamine dimesylate and atomoxetine in child and adolescent subgroups from a head-tohead, double-blind, randomized trial in patients with attention-deficit/hyperactivity disorder

2014 · R.W. Dittmann, E. Cardo, et al. · European Psychiatry

P.7.a.001 Pharmacological treatment versus neurofeedback in typical symptomatology of attention deficit hyperactivity disorder

2013 · E. Cardo, M. Servera, et al. · European Neuropsychopharmacology

P.7.d.008 Efficacy of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with ADHD: head-to-head responder analyses

2013 · E. Cardo, D. Coghill, et al. · European Neuropsychopharmacology

Exposición Prenatal Al Hexaclorobenceno Y Desarrollo Neuroconductual a Las 6-8 Semanas De Vida

1999 · Núria Ribas‐Fitó, Xavier Basagaña, et al. · Gaceta Sanitaria

Niveles De Hexaclorobenceno Y Otros Organoclorados En Recién Nacidos: Transmisión a Través De La Placenta Y De La Lactancia

1999 · María Sala, Xavier Basagaña, et al. · Gaceta Sanitaria

Works count: 21

Citation count: 359

H-index: 8

I10-index: 8